Search results
Found 22 matches for
Mrs Jenny Bellorini, Managing Editor in the Cochrane ENT Disorders Group which is hosted by the Nuffield Department of Surgical Sciences, has won the 2015 Chris Silagy Prize.
Oxford team publish blueprint for making millions of doses of a new vaccine within 100 days
Coronavirus COVID-19 Research
21 December 2021
The University of Oxford’s vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against new virus variants or other future pandemics.
New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection
Coronavirus COVID-19 Publication Research
3 August 2021
Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.
Oxford’s researchers on the frontline
Coronavirus COVID-19
7 January 2021
We rightly hear a lot about Oxford’s vaccine, Covid-19 research and RECOVERY drug trials, but there are also countless personal stories, which display just how broad Oxford’s response to the pandemic has been. It is the contribution and commitment of many individuals that has enabled Oxford’s Medical Sciences Division to become a global leader.
Cochrane ENT awarded NIHR funding for COVID-19 project
Awards and appointments Coronavirus COVID-19 Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Coronavirus COVID-19 Publication Research
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 Research University
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
NDS work experience goes virtual
Coronavirus COVID-19 Department Public engagement
23 July 2020
The Nuffield Department of Surgical Sciences (NDS) during lockdown launched a brand-new virtual work experience programme for students interested in pursuing a career in science and medicine.
Varying risk of COVID-19 to health workers revealed
Coronavirus COVID-19 General Research
2 July 2020
A study at Oxford University Hospitals (OUH) NHS Foundation Trust has revealed the different levels of risk faced by healthcare workers dealing with the COVID-19 pandemic.
Amazing fundraising effort supports NHS workers on COVID-19 frontline
Coronavirus COVID-19
13 May 2020
NDS’s own Dr Ying Cui has been working with the Society of Chinese Medical Practitioners and the Oxfordshire Chinese Community and Advice Centre UK to raise funds for personal protective equipment (PPE) for NHS staff.
To the heroes of the pandemic
Coronavirus COVID-19 General
20 April 2020
4th year Oxford Medical School student Alex Grassam-Rowe’s writes on his admiration and respect for colleagues and others pulling together in the fight against COVID-19.